F · Healthcare

MIRUM PHARMAC. DL-0001 (08D)

Biotechnology

MIRUM PHARMAC. DL-0001 (08D) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $4.98B, P/E ratio is 25.00, net margin is -140.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 08D

Market cap
$4.98B
P/E ratio
25.00
Gross profit (TTM)
$463.58M
Net margin
-140.2%

MIRUM PHARMAC. DL-0001 (08D) — FAQ

What is MIRUM PHARMAC. DL-0001's market cap?

MIRUM PHARMAC. DL-0001 (08D) has a reported market cap of $4.98B (data as of 2026-05-24).

What is 08D's P/E ratio?

The price-to-earnings (P/E) ratio for MIRUM PHARMAC. DL-0001 (08D) is 25.00 (data as of 2026-05-24).

Does MIRUM PHARMAC. DL-0001 pay a dividend?

Dividend yield is not available in the current snapshot for MIRUM PHARMAC. DL-0001 (08D). Check the MyAverix Finance app for the latest dividend data.

What sector is MIRUM PHARMAC. DL-0001 in?

MIRUM PHARMAC. DL-0001 (08D) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 08D listed on?

08D is listed on F.

What is MIRUM PHARMAC. DL-0001's net margin?

MIRUM PHARMAC. DL-0001 (08D) reports a net margin of -140.2% (data as of 2026-05-24).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play